I. General Considerations Regarding Coronary Angiography
Coronary angiography is defined as the radiographic visualization of the coronary vessels after injection of radiopaque contrast media. It is most commonly performed with specialized intravascular catheters. The procedure is usually included as part of cardiac catheterization, which may also involve angiography of other vascular structures, such as the aorta and left ventricle.
The purpose of coronary angiography is to define the coronary anatomy and the degree of luminal obstruction of the coronary arteries. It is most commonly used to determine the presence and extent of obstructive coronary artery disease (CAD) and to assess the feasibility and appropriateness of various forms of therapy, such as revascularization by percutaneous or surgical interventions. It is also used when the diagnosis of coronary disease is uncertain and coronary disease cannot be reasonably excluded by noninvasive techniques.
The risk of major complications is Ͻ2%, but factors such as the stability of the patient's condition, the presence of shock, acute renal insufficiency, and cardiomyopathy significantly increase risk. A number of relative contraindications to the procedure have been reported. Of these, preexisting renal failure, particularly in a patient with diabetes, and a history of prior anaphylactic reaction to contrast medium require special attention before coronary angiography to reduce the risk of subsequent complications.
Cardiac catheterization was performed in Ͼ1 000 000 patients in 1993, making it the second most frequent in-hospital operative procedure performed in the United States. Approximately 48% of all catheterizations are performed in patients Ն65 years. The use of catheterization continues to grow. Given the predicted growth in population and aging of the population, it is possible that by 2010 3 000 000 procedures will be performed annually in the United States. The striking variations in use of coronary angiography in the United States have led to concerns about its appropriateness. A number of studies have evaluated this issue, and the results suggest that the incidence of inappropriate use of coronary angiography is relatively low, ranging from 4% to 18%.
II. Coronary Angiography for Specific Conditions
A. Known or Suspected CAD
Stable Angina
Patients with CAD may become symptomatic in many ways, but most commonly develop angina pectoris. Not all stable chest pain syndromes are truly anginal. It has been suggested that it is useful to characterize chest pain as typical angina, probable angina, and nonspecific chest pain because these groupings are predictive of the presence of CAD. Asymptomatic patients with known or suspected CAD have had no symptoms to suggest cardiac ischemia in the previous 6 weeks. A subgroup of these patients have silent ischemia when tested noninvasively. In general, the results of these tests are related to the functional severity of CAD and are predictors of outcome, independent of the perception of or severity of symptoms. The term known coronary artery disease means that CAD has been documented by either angiography or prior confirmed myocardial infarction (MI). Asymptomatic patients with known CAD form 1 group of patients who were never symptomatic but in whom CAD was documented for other reasons. A second group includes those who were previously symptomatic but who are currently asymptomatic. The term suspected coronary artery disease refers to the presence of clinical characteristics that suggest high risk for CAD and its related adverse outcomes in asymptomatic patients.
Treatment of symptomatic patients should include assessment of severity of angina. The CCS classification of angina provides a useful guide for assessment of typical or probable angina. Severely symptomatic patients (CCS class III or IV) should undergo coronary angiography after medical therapy. Coronary angiography should also be considered for patients treated medically who demonstrate serial deterioration on noninvasive testing but who do not have high-risk features as well as patients whose angina accelerates or intensifies despite adequate medical therapy. Rarely, patients with minimal symptoms whose occupation poses a risk to themselves or others should also undergo coronary angiography, even in the absence of high-risk markers for adverse outcome. Those patients with stable angina who respond to therapy and are currently asymptomatic should undergo noninvasive testing for risk stratification. Table 1 summarizes noninvasive test results that predict high risk for adverse outcome. High-risk patients are defined as those who are expected to have reduced event-free survival, such as patients with underlying left main coronary artery stenosis or severe multivessel disease. In general, the lower the resting left ventricular ejection fraction (LVEF), the higher the risk for adverse outcome. Figure 1 explains the Duke Treadmill Score and its relationship to prognosis. Even when multiple clinical findings suggest the likelihood of significant underlying coronary 1. The observed amount of exercise-induced ST-segment deviation (the largest elevation or depression after resting changes have been subtracted) is marked on the line for ST-segment deviation during exercise. 2. The observed degree of angina during exercise is marked on the line for angina. 3. The marks for ST-segment deviation and degree of angina are connected with a straight edge. The point where this line intersects the ischemia reading line is noted. 4. The total number of minutes of exercise in treadmill testing according to the Bruce protocol (or the equivalent in multiples of resting oxygen consumption [METs] from an alternative protocol) is marked on the exercise-duration line. 5. The mark for ischemia is connected with that for exercise duration. The point at which this line intersects the line for prognosis indicates the 5-year survival rate and average annual mortality for patients with these characteristics. Patients with Ͻ1 mm of exercise-induced ST-segment depression should be counted as having 0 mm. Angina during exercise refers to typical effort angina or an equivalent exercise-induced symptom that represents the patient's presenting complaint. This nomogram applies to patients with known or suspected CAD, without prior revascularization or recent MI, who undergo exercise testing before coronary angiography.
Modified disease, it is important to have objective markers from noninvasive tests to help predict outcome. A scheme for noninvasive evaluation of a patient with suspected coronary disease is shown in Figure 2 . Noninvasive procedures for identifying patients with stress-induced ischemia, especially those at high risk for adverse outcome, should remain the primary means of risk stratification. There is general agreement that coronary angiography is indicated for patients found to have high-risk abnormalities on noninvasive testing. There is varying opinion as to when coronary angiography should be performed in asymptomatic patients for whom noninvasive testing indicates ischemia (ie, a high probability of CAD), but test criteria do not indicate a high risk for adverse outcome. In this subgroup, the presence of multiple clinical risk factors such as increased age or diabetes, occupation, or lifestyle become increasingly important considerations in determining whether coronary angiography should be performed. However, it should be recognized that no controlled studies show an advantage for angiography or revascularization for any of these clinical subsets.
Although it has become common practice to perform periodic coronary angiography after heart transplantation, the prognostic benefit of this practice has not been clearly established.
Adult patients successfully resuscitated from cardiac arrest who do not have clinical findings that suggest other causes generally have extensive CAD. In the absence of recognized precipitating factors such as acute MI, these patients are at high risk for recurrent cardiac arrest, and coronary angiography is of value in determining the underlying cause and planning the most appropriate therapeutic approach. 
Recommendations for Coronary Angiography in

Recurrence of Ischemia After Revascularization
Most revascularization procedures are performed when there is likely to be a survival benefit for patients with a high risk for adverse outcome or when there is a large amount of myocardium at risk. Therefore, postrevascularization recurrence of ischemia in these patients is generally managed aggressively.
Acute coronary closure complicates 2% to 11% of percutaneous coronary interventions and is associated with a high incidence of complications. Coronary angiography is generally performed emergently on any patient with suspected abrupt closure with the intent to repeat intervention, if possible.
Recurrence of stenosis after percutaneous transluminal coronary intervention is still the major limitation to long-term clinical success of the procedure. A distinction should be made between clinical and angiographic restenosis. Clinical, ie, symptomatic restenosis, should be suspected in patients who present with recurrent angina within 9 months of a catheter-based revascularization procedure. Coronary angiography is generally performed in symptomatic patients with suspected restenosis to reassess anatomy and repeat revascularization as needed. Although coronary angiography may reveal angiographic restenosis in asymptomatic postangioplasty patients who have a positive stress test result, these patients generally have a good outcome, and asymptomatic angiographic restenosis may regress. Therefore, the committee recommends against routine noninvasive evaluation of asymptomatic patients after angioplasty. When noninvasive testing is done in asymptomatic patients and reveals high-risk markers for adverse outcome, coronary angiography is indicated.
Patients with prior coronary artery bypass surgery who develop postoperative angina represent an important subset of patients who require aggressive therapy. Graft obstruction within 1 to 2 months of surgery is generally related to a technical problem and can often be treated with percutaneous techniques as can graft disease within the first year. There are no data that compare outcomes in patients with late postoperative angina or ischemia who are treated medically with those treated with revascularization techniques. Most bypass patients who are suitable candidates for further revascularization and who have noninvasive evidence of high risk for adverse outcome are appropriate subjects for coronary angiography. Those who are symptomatic but deemed to be low risk by noninvasive testing can be treated medically before angiography is considered. 
Recommendations for Coronary Angiography in
Acute MI
Although coronary angiography may be performed during or after MI solely for diagnostic purposes, the vast majority of studies are done to evaluate the patient for a percutaneous or surgical revascularization procedure. Therefore, the appropriateness of performing coronary angiography after MI is, by necessity, linked to the efficacy of these revascularization procedures as measured by improved outcome for the patient. Guidelines covering PTCA, coronary artery bypass graft surgery, and management of acute MI have been published by the ACC/AHA Task Force on the Assessment of Diagnostic and Therapeutic Procedures within the past 5 years and include recommendations relevant to the use of coronary angiography.
In practical terms, the use of coronary angiography in patients with acute MI is considered during 3 separate time periods. The first is related to the use of coronary angiography during recognition and treatment of MI in the emergency department. It is only applicable to patients who present with an acute evolving MI within a time frame when reperfusion therapy will likely be beneficial. It is useful to stratify these patients by the presence or absence of ST-segment elevation on the ECG. Because clinical outcomes, especially with thrombolysis, are similar, the committee included in the group with ST-segment elevation patients with typical ischemic chest pain and a new or presumed new left bundle-branch block (BBB) obscuring the ECG diagnosis of MI. In the presence of ongoing ischemic chest pain and ST-segment elevation (or left BBB), the clinician must quickly weigh the risks and benefits of reperfusion therapy and determine whether to use thrombolysis or mechanical techniques. Patients with ongoing ischemic chest pain but without STsegment elevation are a distinct group with different indications for coronary angiography compared with those with ST-segment elevation.
The second time period relates to the use of coronary angiography during the hospital-management phase, after completion of reperfusion therapy, if used, or immediately if reperfusion therapy is not used. Throughout the remainder of the hospital-management phase, the clinician is mainly concerned with treatment of various complications, such as arrhythmia, heart failure, or recurrent ischemia that may develop.
The final time period is defined not by a specific time but rather by evaluations to determine the risk of future morbid events and the need for additional therapies. In these guidelines, the risk stratification phase refers to testing specifically performed in the patient with MI to determine if high-risk indicators are present.
For a broad discussion of management and risk stratification (Figure 3 ) of patients with acute MI, the reader is referred to the full report of this committee and the 1996 "ACC/AHA Guidelines for the Management of Acute Myocardial Infarction." 
Recommendations for Coronary
Perioperative Coronary Angiography for Patients Undergoing Noncardiac Surgery
The perioperative evaluation of patients undergoing noncardiac surgery was recently detailed in the "ACC/AHA Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery." This document outlines a comprehensive approach to perioperative risk assessment that stresses the patient's prior clinical indicators of coronary heart disease, functional status, type of noncardiac surgery, and the role of selected preoperative stress testing in patients thought to be at intermediate or high risk for major perioperative coronary events.
Generally, in patients who are being considered for noncardiac surgery, the indications for coronary angiography should be identical to those outlined in this document. However, the presentation for noncardiac surgery, its potential urgency, the level of cardiovascular stress anticipated, and the patient's general condition all play critical roles in determining the most logical sequence of events for a given patient.
Recommendations for Coronary Angiography in Perioperative Evaluation Before (or After) Noncardiac Surgery
In all forms of valvular heart disease, the presence of significant coronary disease worsens prognosis. Most practitioners feel compelled to assess coronary anatomy before valve surgery and to bypass significant obstructions during surgery with the hope of avoiding late reoperation. Although there are no large clinical trials to prove its value, angiography seems to play an important role in the preoperative evaluation of patients with valvular heart disease.
That role continues to evolve. All patients with chest pain or noninvasive evidence of coronary disease should undergo coronary angiography. It still seems prudent to perform coronary angiography in patients who are at increased risk for coronary disease because of age or other risk factors.
